Literature DB >> 29691517

Is 'friendly fire' in the brain provoking Alzheimer's disease?

Alison Abbott.   

Abstract

Entities:  

Keywords:  Alzheimer's disease; Immunology; Neuroscience

Mesh:

Substances:

Year:  2018        PMID: 29691517     DOI: 10.1038/d41586-018-04930-7

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  15 in total

Review 1.  A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease.

Authors:  Francesco Panza; Bruno P Imbimbo; Madia Lozupone; Giancarlo Logroscino
Journal:  Nat Rev Neurol       Date:  2019-02       Impact factor: 42.937

2.  Icariside II inhibits lipopolysaccharide-induced inflammation and amyloid production in rat astrocytes by regulating IKK/IκB/NF-κB/BACE1 signaling pathway.

Authors:  Yong Zheng; Yan Deng; Jian-Mei Gao; Chun Lv; Ling-Hu Lang; Jing-Shan Shi; Chang-Yin Yu; Qi-Hai Gong
Journal:  Acta Pharmacol Sin       Date:  2019-09-25       Impact factor: 6.150

3.  Glioma and Alzheimer's Disease.

Authors:  Steven Lehrer
Journal:  J Alzheimers Dis Rep       Date:  2018-12-14

4.  A rare functional variant of SHARPIN attenuates the inflammatory response and associates with increased risk of late-onset Alzheimer's disease.

Authors:  Yuya Asanomi; Daichi Shigemizu; Akinori Miyashita; Risa Mitsumori; Taiki Mori; Norikazu Hara; Kaoru Ito; Shumpei Niida; Takeshi Ikeuchi; Kouichi Ozaki
Journal:  Mol Med       Date:  2019-06-20       Impact factor: 6.354

5.  Aggregated Tau activates NLRP3-ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo.

Authors:  Ilie-Cosmin Stancu; Niels Cremers; Hannah Vanrusselt; Julien Couturier; Alexandre Vanoosthuyse; Sofie Kessels; Chritica Lodder; Bert Brône; François Huaux; Jean-Noël Octave; Dick Terwel; Ilse Dewachter
Journal:  Acta Neuropathol       Date:  2019-02-05       Impact factor: 17.088

Review 6.  Challenges to curing primary brain tumours.

Authors:  Kenneth Aldape; Kevin M Brindle; Louis Chesler; Rajesh Chopra; Amar Gajjar; Mark R Gilbert; Nicholas Gottardo; David H Gutmann; Darren Hargrave; Eric C Holland; David T W Jones; Johanna A Joyce; Pamela Kearns; Mark W Kieran; Ingo K Mellinghoff; Melinda Merchant; Stefan M Pfister; Steven M Pollard; Vijay Ramaswamy; Jeremy N Rich; Giles W Robinson; David H Rowitch; John H Sampson; Michael D Taylor; Paul Workman; Richard J Gilbertson
Journal:  Nat Rev Clin Oncol       Date:  2019-08       Impact factor: 66.675

7.  The Immune System Drives Synapse Loss During Lipopolysaccharide-Induced Learning and Memory Impairment in Mice.

Authors:  Yi-Rong Xin; Jun-Xing Jiang; Yang Hu; Jun-Ping Pan; Xiang-Nan Mi; Qin Gao; Fei Xiao; Wei Zhang; Huan-Min Luo
Journal:  Front Aging Neurosci       Date:  2019-11-15       Impact factor: 5.750

8.  A dual inhibitor of the proteasome catalytic subunits LMP2 and Y attenuates disease progression in mouse models of Alzheimer's disease.

Authors:  In Jun Yeo; Min Jae Lee; Ahruem Baek; Zachary Miller; Deepak Bhattarai; Yu Mi Baek; Hyun Jung Jeong; Yun Kyung Kim; Dong-Eun Kim; Jin Tae Hong; Kyung Bo Kim
Journal:  Sci Rep       Date:  2019-12-05       Impact factor: 4.379

9.  Removal of Aβ Oligomers from the Blood: A Potential Therapeutic System for Alzheimer's Disease.

Authors:  Yuta Saito; Miwa Sakata; Moe Kobayakawa; Hiroshi Kawachi; Kazunori Kawaguchi; Yoshiyuki Hiki; Masao Kato; Mayuko Mori; Midori Hasegawa; Norimi Ohashi; Yukio Yuzawa; Nobuya Kitaguchi
Journal:  Neuropsychiatr Dis Treat       Date:  2020-03-03       Impact factor: 2.570

Review 10.  Emerging PET Radiotracers and Targets for Imaging of Neuroinflammation in Neurodegenerative Diseases: Outlook Beyond TSPO.

Authors:  Vidya Narayanaswami; Kenneth Dahl; Vadim Bernard-Gauthier; Lee Josephson; Paul Cumming; Neil Vasdev
Journal:  Mol Imaging       Date:  2018 Jan-Dec       Impact factor: 4.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.